{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:08:52Z","timestamp":1759529332055},"reference-count":17,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ejps.2013.04.030","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T11:54:33Z","timestamp":1367582073000},"page":"767-772","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats"],"prefix":"10.1016","volume":"49","author":[{"given":"Lassina","family":"Badolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoffer","family":"Bundgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Garmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bente","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2013.04.030_b0005","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejps.2010.03.023","article-title":"Screening of OATP1B1\/3 and OCT1 inhibitors in cryopreserved hepatocytes in suspension","volume":"40","author":"Badolo","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.04.030_b0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/dmd.107.018200","article-title":"Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in freshly isolated rat hepatocytes","volume":"36","author":"Bow","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2013.04.030_b0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.LAB.0000065015.02412.48","article-title":"Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma","volume":"83","author":"Cui","year":"2003","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejps.2013.04.030_b0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2013.04.030_b0025","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/00498250801986951","article-title":"Xenobiotic transporters of the human organic anion transporting polypeptides (OATPs) family","volume":"38","author":"Hagenbuch","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2013.04.030_b0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/03602530601093489","article-title":"Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies","volume":"39","author":"Hewitt","year":"2007","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejps.2013.04.030_b0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejps.2011.09.001","article-title":"Time-course activities of Oct1, Mrp3, and cytochrome P450s in cultures of cryopreserved rat hepatocytes","volume":"44","author":"Jacobsen","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.04.030_b0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejps.2006.11.003","article-title":"Evidence of Oatp and Mdr1 in cryopreserved rat hepatocytes","volume":"30","author":"Jorgensen","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.04.030_b0055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2013.04.030_b0045","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0091270007311569","article-title":"Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide","volume":"48","author":"Kalliokoski","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2013.04.030_b0050","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1742-7843.2010.00581.x","article-title":"SLCO1B1 polymorphism and oral antidiabetic drugs","volume":"107","author":"Kalliokoski","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2013.04.030_b0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11095-006-9159-2","article-title":"Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans","volume":"24","author":"Kivisto","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2013.04.030_b0065","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1517\/17425255.2012.678048","article-title":"Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability \u2013 considerations for drug development","volume":"8","author":"Lai","year":"2012","journal-title":"Exp. Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejps.2013.04.030_b0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.111.187112","article-title":"Simultaneous assessment of uptake and metabolism in rat hepatocytes: a comprehensive mechanistic model","volume":"341","author":"Menochet","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2013.04.030_b0075","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clpt.2005.01.018","article-title":"Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics","volume":"77","author":"Niemi","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2013.04.030_b0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003088-200746020-00001","article-title":"Drug\u2013drug and food\u2013drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide","volume":"46","author":"Scheen","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2013.04.030_b0085","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/clpt.2011.351","article-title":"Transporter-mediated drug\u2013drug interactions involving OATP substrates: predictions based on in vitro inhibition studies","volume":"91","author":"Yoshida","year":"2012","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098713001735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098713001735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T06:52:07Z","timestamp":1539672727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098713001735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0928098713001735"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2013.04.030","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2013.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}